Snapshot Highlights
- Over two decades of dedicated experience in Gynecologic Oncology and Obstetrics.
- Expertise in advanced procedures including Robotic Surgery and In Vitro Fertilization (IVF).
- Board-certified in Gynecological Oncology Surgery with extensive international training.
- Key leadership roles in prestigious medical associations, including FIGO and Turkish Urogynecology Association.
- Extensive publication record in reputable peer-reviewed journals.
Dr. FUAT DEMIRCI
Professional Journey and Expertise
Dr. Fuat Demirci is a highly accomplished specialist in Gynecologic Oncology, with a distinguished career spanning over two decades. His extensive expertise encompasses a broad spectrum of women’s health, including comprehensive Gynecological Obstetrics, In Vitro Fertilization (IVF) Centers, Menopause management, and the treatment of complex conditions such as Endometriosis and Urinary Incontinence. He is recognized for his advanced skills in Urogynecology and Pelvic Reconstructive Surgery, addressing critical aspects of bladder health and sexual dysfunctions.
Education and Board Certification
Dr. Demirci’s foundational medical education was completed at Istanbul University Istanbul Faculty of Medicine in 1983. He further honed his skills in Gynecology and Obstetrics at the Zeynep Kamil Women and Children’s Diseases Training and Research Hospital in 1990. His academic career progressed significantly at Abant İzzet Baysal University, Düzce Faculty of Medicine, where he served as an Assistant Professor, Associate Professor, and ultimately Professor Doctor between 1997 and 2008. Demonstrating his commitment to specialized knowledge, he achieved his Medical Specialization Board certification in Gynecological Oncology Surgery in 2011.
Advanced Training and Experience
Dr. Demirci’s commitment to advancing medical techniques is evident through his comprehensive international training. He received mesh training at Delorme’s Clinic in France in 2012 and obtained Robotic Surgery certification from IRCAD in Strasbourg, France, in 2011. His expertise in Assisted Reproductive Technologies (IVF) was further solidified with a certificate from Yeditepe University Faculty of Medicine in 2009. He gained valuable experience in Urogynecology and Oncology at Rostock University in Germany (2000) and at Baylor College of Medicine in Houston, Texas, USA (1995), specializing in Urogynecology.
Professional Affiliations and Leadership
Dr. Demirci is a respected figure within the medical community, holding significant roles in numerous esteemed organizations. He has served on the board of directors for the Turkish Association of Gynecology and Obstetrics (TJOD) from 2004 to 2010 and as a board member from 2012 to 2016. His international influence is marked by his advisory board membership for the Federation of International Gynecology and Obstetrics (FIGO) in 2004 and his role in the Mediterranean Incontinence and Pelvic Floor Society (MIPS) advisory board since 2017. He has also been instrumental in shaping the field of urogynecology as the President, Founding Secretary General, and Board Member of the Turkish Urogynecology and Pelvic Reconstructive Surgery Association since 1997. His memberships extend to prominent societies such as the International Continence Society (ICS), European Society of Gynecological Oncology (ESGO), International Urogynecology Association (IUGA), Gynecological Endoscopy Association, Society of European Robotic Gynecologic Surgery (SERGS), and the European Society of Endoscopic Surgery (ESGE).
Research and Publications
Dr. Demirci has made substantial contributions to medical literature through his extensive research and publications. His work focuses on critical areas of gynecologic surgery and patient care. Notable publications include research on perioperative complications in procedures like abdominal sacrocolpopexy and sacrospinous ligament fixation, the impact of hormone therapy on menopausal women, and the effectiveness of various surgical techniques for genuine stress incontinence and paravaginal defect repair. His research also delves into topics such as the effects of tibolone versus 17ß-estradiol on climacteric symptoms and the management of rare conditions like pure ovarian choriocarcinoma during pregnancy, showcasing a commitment to evidence-based practice and advancing the field of gynecologic oncology and urogynecology.